Stem Cell Oncology-Pipeline Insights, 2015
DelveInsight, the leading market research and consulting company has added new report Stem Cell Oncology-Pipeline Insights, 2015 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides their clients... - October 14, 2015
PD-1 and PD-L1 Inhibitors and Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2015
DelveInsight, the leading market research and consulting company has received immense positive feedback on its report PD-1 and PD-L1 inhibitors and Chimeric Antigen Receptor (CAR)-T cell Immunotherapy - Competitive Landscape, Pipeline and Market Analysis, 2015.. In addition to this their research... - August 22, 2015
Celiac Disease-Pipeline Insights, 2015 - a DelveInsight Report
DelveInsight, the leading market research and consulting company has added new report Celiac Disease-Pipeline Insights, 2015 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this our research expertise provides our clients with up... - August 21, 2015
Acne Vulgaris - API Insights - A DelveInsight Report
DelveInsight, the leading market research and consulting company has added new report, Acne Vulgaris-API Insights, 2015 to its portfolio. With this launch Delveinsight now has 400+ Reports on Indication API Insight. DelveInsight is the only company that promulgates API Insight Reports. In addition... - July 24, 2015
DelveInsight’s Oncology Based Reports, 2015
DelveInsight, the leading market research and consulting company has added Oncology based Reports to its portfolio. With this launch DelveInsight now has 100+ Oncology based Reports. In addition to this, their research expertise provides their clients with up to date information of market till the date on which order is placed. - July 17, 2015
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-API Insights, 2015
DelveInsight, the leading market research and consulting company has added new report, "Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)-API Insights, 2015" to its portfolio. With this launch DelveInsight now has 400+ Reports on Indication API Insight. DelveInsight is the only... - July 15, 2015
DelveInsight’s Drug Active Pharmaceutical Ingredient Reports – 2015
DelveInsight, leading Market Research and Business Consulting firm has an expertise in providing business solutions to Pharma and biotech companies. DelveInsight has 400+ drug API reports which provide marketed drug and API Manufacturers details across the globe along with the location. - July 10, 2015
DelveInsight Appoints Dr. Vishal Agrawal as New CEO
DelveInsight Business Research (DelveInsight), the leading Business Consultant and Market Research Firm with 3000+ Strategic Reports and 100+ clients worldwide, is providing commendable client services for last one year. Today, the firm announced that Dr. Vishal Agrawal has joined the company as... - July 03, 2015
Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy- Competitive Landscape 2015-A DelveInsight Report
DelveInsight CAR-T cell therapy Report provides a comprehensive study of the pipeline drugs, acquisitions, collaborations & deals, licensing opportunities, competitor analysis and technologies being developed by biopharmaceutical firms. - July 03, 2015
DelveInsight Strategic Report: PD-1 and PD-L1 Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2015
DelveInsight has launched its PD-1 and PD-L1 inhibitors Report giving Pipeline and global Market Outlook. - June 06, 2015
DelveInsight Portfolio Reached 3000+ Reports in Less Than One Year
DelveInsight has released 3000+ Reports in market based on indication, MOA, API, drug, Gene Therapy, Anticoagulants, ADC and PD-1 and PDL-1. - April 23, 2015
Coming Soon: DelveInsight Brand New Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015 Report
DelveInsight has launched its Antibody-Drug Conjugate Report giving Pipeline and global Market Outlook. - April 09, 2015
DelveInsight Released Top Line Analytical Reports on Blood Coagulation and Cancer Markets
DelveInsight has highlighted current and future market of Anticoagulants and Programmed cell death 1 (PD-1) Inhibitors. - April 09, 2015
Promotional Offer on DelveInsight’s Gene Therapy Reports
DelveInsight, a Market Research & Business Consulting firm, has started a promotional offer on its Gene therapy reports highlighting their on-going demand across the globe. These reports provide detailed insight for 15 Therapy areas covering more than 300 gene therapies along with the companies... - February 14, 2015
DelveInsight "On Demand" Reports 2015 - The Updated Version of 2014 Released Reports
DelveInsight "On Demand" Reports 2015 is the most up to date and customizable Report in the market. These Reports are marketed under three Brands i.e. Pharm Delve, Pharm Insights and Pharm API. - January 15, 2015
DelveInsight Launching Gene Therapy Reports Highlighting 15 Therapy Areas
DelveInsight Gene therapy report highlights the profiles of Industry collective pipeline of 300+ Gene Therapies with prediction of early market winners using DelveInsight Competitive Matrix model. - January 15, 2015
Get the First Mover Advantage in “The Big Value” Gene Therapy Market
Take Advantage of the very lucrative gene therapy market and play in the rare-air of the very few with DelveInsight’s Gene Therapy Reports! - December 07, 2014
Discount on DelveInsight’s Market & Pipeline Reports Till 26th December, 2014
Meet your Targets with DelveInsight's Comprehensive Reports which are now available at a lesser price. - December 03, 2014
The “New” Way Forward: DelveInsight’s Oncology-Based MOA Pipeline Reports
Move one Step ahead from the Market with These Target-Based Reports. - November 28, 2014
DelveInsight Launched 500 API Reports: Pharm API
DelveInsight has launched 500 API Insights Reports in the market based on drugs and Indications. - November 08, 2014
Brain Hemorrhage-Pipeline Insights, 2014
DelveInsight’s, “Brain Hemorrhage-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Brain Hemorrhage. This report... - August 20, 2014
Rheumatoid Arthritis - Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
DelveInsight’s, “Rheumatoid Arthritis-Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish... - August 20, 2014
Delveinsight Picks Up the Pace with Its Newly Launched Drug Pipeline Reports
Overthe past six months, DelveInsight has proven its value to their customers with its excellent deliverables. Now newly launched DelveInsight's Pipeline Reports is the answer to all looking for top notch drug development information. - August 10, 2014
Successful Launch of Mechanism of Action Based Pipeline Reports by DelveInsight
Get the idea what other companies are doing with the targets you are interested in and what their progress and strategize to get the best out of it with MOA Pipeline Reports. - July 30, 2014
Delveinsight , a Business Consultant and Market Research Firm Released 900+ Indication and Drug Reports
The DelveInsight released reports via Pharm Delve series based on Indication and Drugs which provides Insights on Drugs, Active ingredient Intelligence, Generic/ Pipeline Intelligence and Company Intelligence. - July 11, 2014
DelveInsight Business Research, a Business Consultant and Knowledge Partner, Started Operations in Delhi
DelveInsight Business Research, a start up market research and business consulting firm has started their office in Delhi. DelveInsight is the premier source of actionable insights into healthcare industries across US, Europe, India, China and all emerging markets. With the combined expertise of... - July 06, 2014